Material Agreements

Capstone Holding Corp. amended Amended and Restated Common Stock Purchase Agreement with an accredited investor valued at $20,000,000 in aggregate gross purchase price (effective 2026-06-11).

“On June 11, 2026, the Company and the Investor entered into an Amended and Restated Common Stock Purchase Agreement (the "Purchase Agreement"), which amends, restates, and supersedes the Original Agreement”

SMITH MICRO SOFTWARE, INC. entered into Inducement Letter Agreements with certain holders of existing Common Warrants valued at approximately $1.6 million (effective 2026-06-11).

“On June 11, 2026, Smith Micro Software, Inc., a Delaware corporation (the “Company”), entered into inducement letter agreements (collectively, the “Inducement Letter Agreements”) with certain holders (the “Holders”) of its existing Common Warrants to purchase an aggregate of 487,349 shares of the Company’s common stock”

MCKESSON CORP amended Amendment to Credit Agreement, dated as of April 1, 2026 with JPMorgan Chase Bank, N.A. (as administrative agent) and other lenders valued at Term B loan facility of $2,250.0 million, interest at Adjusted Term SOFR + 2.25% or Base Rate + 1.25 (effective 2026-06-09).

“On June 9, 2026, certain of McKesson Corporation’s (the “Company”) subsidiaries, including McKesson Medical-Surgical Top Holdings, Inc. (the “Borrower”), entered into an amendment (the “Amendment”) to the Credit Agreement , dated as of April 1, 2026, among, the Borrower, the lenders from time to time party thereto and JPMorgan Chase Bank, N.A., as administrative agent and collateral agent (as so amended, the “Credit Agreement”), to provide for a $2,250.0 million senior secured term “B” loan facility due 2032 (the “Term B Loan Facility”).”

UNITED COMMUNITY BANKS INC entered into Stock Purchase Agreement with Navitas TopCo LLC valued at approximately $1,900,000,000 (effective 2026-06-11).

“On June 11, 2026, United Community Bank (the “Bank”), a South Carolina state-chartered bank and wholly owned subsidiary of United Community Banks, Inc. (“United”), entered into a Stock Purchase Agreement (the “Purchase Agreement”), by and among the Bank, Navitas TopCo LLC (“Purchaser”), a Delaware limited liability company, and, solely for the limited purposes set forth therein, United, providing for the sale of all of the issued and outstanding equity securities of Navitas Credit Corp., a Florida corporation and the Bank’s equipment lease financing subsidiary (“Finance Company”), and NLFC Reinsurance Corp., a Tennessee corporation and the Bank’s reinsurance subsidiary (“Reinsurance Company” and together with Finance Company, the “Companies”).”

NEONC TECHNOLOGIES HOLDINGS, INC. entered into Purchase Agreement with certain accredited investors valued at $5,000,000 (effective 2026-06-10).

“On June 10, 2026, NeOnc Technologies Holdings, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain accredited investors (the “Investors”), pursuant to which the Company agreed to issue and sell up to an aggregate of $5,000,000 of its Series A Convertible Preferred Stock (the “Series A Preferred Stock”) in a private placement.”

Qorvo, Inc. amended 2031 Supplemental Indenture with the Company, the 2031 Guarantors and Computershare Trust Company, N.A., as trustee (effective 2026-06-11).

“On June 11, 2026, the Company entered into a first supplemental indenture to the 2031 Indenture, dated as of June 11, 2026 (the “2031 Supplemental Indenture” and, together with the 2029 Third Supplemental Indenture, the “Supplemental Indentures”), by and among the Company, the 2031 Guarantors and the Trustee, giving effect to the 2031 Proposed Amendments.”

Qorvo, Inc. amended 2029 Third Supplemental Indenture with the Company, the 2029 Guarantors and Computershare Trust Company, N.A., as trustee (effective 2026-06-11).

“On June 11, 2026, the Company entered into a third supplemental indenture to the 2029 Indenture, dated as of June 11, 2026 (the “2029 Third Supplemental Indenture”), by and among the Company, the 2029 Guarantors and the Trustee, giving effect to the 2029 Proposed Amendments.”

TILLY'S, INC. amended Second Amendment to Credit Agreement with Wells Fargo Bank, National Association (effective 2026-06-10).

“On June 10, 2026, World of Jeans & Tops, a California corporation and a wholly owned subsidiary of Tilly’s, Inc., a Delaware corporation (the “Company”), as borrower, and the Company, as guarantor, entered into the Second Amendment to Credit Agreement (the “Amendment”), which amends the Credit Agreement (as amended, the “Agreement”), dated as of April 27, 2023, with Wells Fargo Bank, National Association.”

Shoals Technologies Group, Inc. amended Amendment No. 7 to Credit Agreement with Wilmington Trust, National Association, JPMorgan Chase Bank, N.A. valued at $50,000,000 (effective 2026-06-10).

“On June 10, 2026 (the “Effective Date”), Shoals Technologies Group, Inc. (the “Company”), as borrower, and certain of its subsidiaries entered into Amendment No. 7 (the “Amendment”) to the Credit Agreement, dated as of November 25, 2020, with Wilmington Trust, National Association, as Collateral Agent, JPMorgan Chase Bank, N.A., as Administrative Agent, and each L/C issuer and lender from time to time party thereto (as amended prior to the Effective Date, the “Existing Credit Agreement,” and as amended from time to time, the “Amended Credit Agreement”).”

Crypto Co entered into Subscription Agreement with Three Mile Creek Future LLC, Bryn Rodriguez, Ron Levy valued at aggregate purchase price of $300,000 (effective 2026-06-06).

“On June 6, 2026 and June 11, 2026, The Crypto Company (the “ Company ”) executed Subscription Agreements (each, a “ Subscription Agreement ” and collectively, the “ Subscription Agreements ”) with certain institutional and other accredited investors: Three Mile Creek Future LLC, Bryn Rodriguez, and Ron Levy (each, an “ Investor ” and collectively, the “ Investors ”), pursuant to which the Company agreed to sell and issue to the Investors an aggregate of 96,000,000 shares of the Company’s common stock, par value $0.001 (“ Common Stock ”) for an aggregate purchase price of $300,000 in cash, in a private placement transaction exempt from registration under Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), and Rule 506(b) promulgated thereunder.”

Venu Holding Corp entered into Stock Transfer Agreements with Shareholder and entity wholly owned by Shareholder valued at transfer of shares valued at approximately $10,000,000 (effective 2025-06-05).

“Concurrently with the closing of the Sale, and in connection with the PSA to, among other things, facilitate the Loan and to satisfy a condition of the lender, the Company and the Subsidiary entered into Stock Transfer Agreements (collectively, the “ STAs ”) on the Closing Date with each of the Shareholder and an entity wholly owned by the Shareholder (together, the “ Transferors ”).”

Venu Holding Corp entered into Purchase and Sale Agreement with O'Neil Roth Ford, LLC valued at purchase price of $49,700,000 (effective 2025-06-05).

“On June 5, 2026 (the “ Closing Date ”), Notes CS I, DST (the “ Subsidiary ”), a Delaware statutory trust and a controlled subsidiary of Venu Holding Corporation (the “ Company ”), entered into a Purchase and Sale Agreement dated June 5, 2026 (the “ PSA ”) with O’Neil Roth Ford, LLC, a Colorado limited liability company (“ ORF ”).”

IQVIA HOLDINGS INC. entered into Indenture with U.S. Bank Trust Company, National Association valued at €950,000,000 (effective 2026-06-11).

“On June 11, 2026, IQVIA Inc. (the “Issuer”), a wholly owned subsidiary of IQVIA Holdings Inc. (the “Company”), completed the issuance and sale of €950,000,000 in gross proceeds of 4.625% senior notes due 2033 (the “Notes”). The Notes were issued pursuant to an Indenture, dated June 11, 2026 (the “Indenture”), among the Issuer, U.S. Bank Trust Company, National Association, as trustee of the Notes, and certain subsidiaries of the Issuer as guarantors.”

KalVista Pharmaceuticals, Inc. terminated Company 2017 Employee Stock Purchase Plan with KalVista Pharmaceuticals, Inc. valued at Terminated the Company 2017 Employee Stock Purchase Plan (effective 2026-06-11).

“In addition, and also effective immediately prior to, and contingent upon, the Effective Time, the Company terminated the Company 2017 Employee Stock Purchase Plan.”

KalVista Pharmaceuticals, Inc. terminated Company 2015 Incentive Plan with KalVista Pharmaceuticals, Inc. valued at Terminated the Company 2015 Incentive Plan, the Company 2017 Equity Incentive Plan, and the Company (effective 2026-06-11).

“In connection with the consummation of the Offer and the Merger and effective as of, and contingent upon, the Effective Time, the Company terminated the Company 2015 Incentive Plan, the Company 2017 Equity Incentive Plan, and the Company 2021 Equity Inducement Plan.”

Humacyte, Inc. entered into Underwriting Agreement with Barclays Capital Inc., BTIG, LLC and Titan Partners Group LLC, a division of American Capital Partners, LLC, as representatives of the several underwriters named therein valued at approximately $46.80 million (effective 2026-06-10).

“On June 10 , 2026, Humacyte, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Barclays Capital Inc., BTIG, LLC and Titan Partners Group LLC, a division of American Capital Partners, LLC, as representatives of the several underwriters named therein (collectively, the “Underwriters”), relating to the issuance and sale in an underwritten offering (the “Offering”), pursuant to which the Company agreed to issue and sell 47,619,048 shares of the Company’s common stock, $0.0001 par value per share, at a price to the public of $1.05 per share (the “Firm Shares”).”

VEEA INC. entered into Share Issuance Agreement with four existing investors (effective 2026-06-08).

“Share Issuance Agreements On June 8, 2026, the Company, entered into Share Issuance Agreements (each a “ Share Issuance Agreement ” and collectively, the “ Share Issuance Agreements ”) with four existing investors (each a “ Share Issuance Investor ” and collectively, the “ Share Issuance Investors ”), pursuant to which the Share Issuance Investors agreed that in consideration for their releasing the Company from any liability or damages in connection with the late delivery of shares of Common Stock upon the prior automatic conversion of their Notes”

VEEA INC. entered into Note Conversion Agreement with two existing investors valued at $750,000 (effective 2026-06-08).

“Note Conversion Agreements On June 8, 2026, Veea Inc., a Delaware corporation (the “ Company ”), entered into Note Conversion Agreements (each a “ Note Conversion Agreement ” and collectively, the “ Note Conversion Agreements ”) with two existing investors (each a “ Note Conversion Investor ” and collectively, the “ Note Conversion Investors ”), pursuant to which the Note Conversion Investors agreed, with respect to an unsecured convertible note issued to each of them on September 13, 2024 (each a “ Note ” and collectively, the “ Notes ”), which Notes both matured on March 13, 2026, to the automatic conversion of the principal and accrued interest under the Notes into shares of the Company’s common stock”

RMG ML Sports Holdings entered into Private Placement Units Purchase Agreement with RMG ML Sports Holdings Sponsor LLC valued at Private Placement Units Purchase Agreement between Company and Sponsor (effective 2026-06-09).

“etter Agreement, dated June 9, 2026, by and among the Company, RMG ML Sports Holdings Sponsor LLC (the “ Sponsor ”) and each of the officers and directors of the Company, a copy of which is attached as Exhibit 10.1 hereto and is incorporated herein”

RMG ML Sports Holdings entered into Registration Rights Agreement with RMG ML Sports Holdings Sponsor LLC valued at Registration Rights Agreement between Company and Sponsor (effective 2026-06-09).

“etter Agreement, dated June 9, 2026, by and among the Company, RMG ML Sports Holdings Sponsor LLC (the “ Sponsor ”) and each of the officers and directors of the Company, a copy of which is attached as Exhibit 10.1 hereto and is incorporated herein”

RMG ML Sports Holdings entered into Investment Management Trust Agreement with Continental Stock Transfer & Trust Company valued at Investment Management Trust Agreement with Continental Stock Transfer & Trust Company as trustee (effective 2026-06-09).

“An Investment Management Trust Agreement, dated June 9, 2026, by and between the Company and Continental Stock Transfer & Trust Company, as trustee”

RMG ML Sports Holdings entered into Letter Agreement with RMG ML Sports Holdings Sponsor LLC valued at Letter Agreement among Company, Sponsor, and officers/directors (effective 2026-06-09).

“A Letter Agreement, dated June 9, 2026, by and among the Company, RMG ML Sports Holdings Sponsor LLC (the “ Sponsor ”) and each of the officers and directors of the Company”

RMG ML Sports Holdings entered into Rights Agreement with Continental Stock Transfer & Trust Company valued at Rights Agreement for one right to receive one-eighth of one Ordinary Share upon business combination (effective 2026-06-09).

“A Rights Agreement, dated June 9, 2026, by and between the Company and Continental Stock Transfer & Trust Company, as rights agent”

RMG ML Sports Holdings entered into Underwriting Agreement with Santander US Capital Markets LLC valued at Underwriting Agreement for IPO of 20,000,000 units at $10.00 per unit, gross proceeds $200,000,000 (effective 2026-06-09).

“nderwriting Agreement, dated June 9, 2026 by and between the Company and Santander US Capital Markets LLC, as representative of the”

Hyperscale Data, Inc. entered into Pre-Paid Advance Agreement with YA II PN, Ltd. valued at $15,958,000 (effective 2026-06-11).

“On June 11, 2026 (the “ Effective Date ”), Hyperscale Data, Inc. (the “ Company ”) entered into a Pre-Paid Advance Agreement (the “ PPA ”) with YA II PN, Ltd., a Cayman Islands exempt limited partnership (“ Yorkville ”).”

DANA Inc entered into Separation and Distribution Agreement with Eaton Corporation plc, Eaton Corporation, Eaton Capital Unlimited Company, Mobility (USA) Corporation (effective 2026-06-10).

“a Separation and Distribution Agreement (the “ Separation Agreement ”), dated as of June 10, 2026, by and among Eaton, Eaton Ohio, Eaton HoldCo, SpinCo and Dana”

DANA Inc entered into Agreement and Plan of Merger with Eaton Corporation plc, Eaton Corporation, Mobility (USA) Corporation, Atlas Mobility Sub, Inc. (effective 2026-06-10).

“an Agreement and Plan of Merger (the “ Merger Agreement ”), dated as of June 10, 2026, by and among Eaton, Eaton Ohio, SpinCo, Merger Sub and Dana”

CIENA CORP entered into Indenture with U.S. Bank Trust Company, National Association valued at $2.875 billion aggregate principal amount (effective 2026-06-11).

“On June 11, 2026, Ciena Corporation (the “Company”) closed its previously announced private offering (the “Offering”) of $2.875 billion aggregate principal amount of the Company’s 0.00% Convertible Senior Notes due 2031 (the “Notes”), which includes $375.0 million aggregate principal amount of Notes issued in connection with the initial purchasers’ full exercise of their option to acquire additional Notes, pursuant to an indenture, dated June 11, 2026 (the “Indenture”), among the Company, the guarantors named therein and U.S. Bank Trust Company, National Association, as trustee.”

BERKLEY W R CORP amended First Amendment to Credit Agreement with Bank of America, N.A., M&T Bank, JPMorgan Chase Bank, N.A., Morgan Stanley Senior Funding, Inc. valued at Extends maturity date of revolving credit facility from April 1, 2027 to June 9, 2031 (effective 2026-06-09).

“On June 9, 2026, W. R. Berkley Corporation (the "Company") entered into the First Amendment (the "Amendment") to that certain Credit Agreement, dated April 1, 2022 (as amended, the "Credit Agreement"), by and among the Company, as borrower, each lender from time to time party to the Credit Agreement, each of M&T Bank, JPMorgan Chase Bank, N.A. and Morgan Stanley Senior Funding, Inc., as Syndication Agents, and Bank of America, N.A., as Administrative Agent, Several L/C Agent and Fronting L/C Issuer.”

AIM ImmunoTech Inc. entered into Placement Agency Agreement with Ladenburg Thalmann & Co. Inc. valued at Cash fee equal to 8.0% and management fee equal to 0.75% of aggregate gross proceeds of Offerings, p (effective 2026-06-09).

“In connection with the Offerings, the Company also entered into a placement agency agreement, dated June 9, 2026 (the “Placement Agency Agreement”), with Ladenburg Thalmann & Co. Inc. (the “Placement Agent”), pursuant to which the Company agreed to pay the Placement Agent a cash fee equal to 8.0%, and a management fee equal to 0.75%, of the aggregate gross proceeds of the Offerings, and reimbursed the Placement Agent for certain expenses and legal fees.”

AIM ImmunoTech Inc. entered into Securities Purchase Agreement with institutional investors valued at Gross proceeds of approximately $1.3 million from Registered Offering, plus potential additional gro (effective 2026-06-09).

“On June 9, 2026, AIM ImmunoTech Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with institutional investors (the “Investors”), pursuant to which the Company agreed to issue and sell to such investors in a registered direct offering 2,554,119 shares (the “Shares”) of common stock, par value $0.001 per share (the “Common Stock”), of the Company, at an offering price of $0.5189 per share (such registered direct offering, the “Registered Offering”).”

Bally's Corp entered into Cooperation Agreement with Evoke PLC valued at Acquisition valued at approximately £243.1 million; all share acquisition with cash alternative capp (effective 2026-06-05).

“On June 5, 2026, Bally’s Intralot S.A. (“Bally’s Intralot”), a Greek publicly listed company in which Bally's Corporation (the "Company") (through its subsidiaries) holds an investment representing approximately 59.44% (as of March 31, 2026) of the outstanding shares, and Evoke PLC, a company incorporated under the laws of Gibraltar and listed on the London Stock Exchange (“Evoke”), issued a joint announcement that their respective Boards of Directors have reached agreement on the terms and conditions of a recommended all share acquisition by Bally’s Intralot for the entire ordinary share capital of Evoke (the “Acquisition”) and in connection with the same have also entered into a Cooperation Agreement dated June 5, 2026 (the “Cooperation Agreement”), by and among Bally's Intralot, Bally's Intralot Jersey Securities Limited, and Evoke.”

Parabilis Medicines, Inc. entered into Stock Purchase Agreement with Regeneron Pharmaceuticals, Inc. valued at aggregate of 4,166,666 shares at 90% of the $20.00 IPO price (effective 2026-06-09).

“On June 9, 2026, Parabilis Medicines, Inc. (the “Company”) entered into a Stock Purchase Agreement (the “Purchase Agreement”) with Regeneron Pharmaceuticals, Inc. (“Regeneron”), for the purchase of an aggregate of 4,166,666 shares (the “Shares”) of its voting common stock, par value $0.0001 (“Common Stock”), at a per share price equal to 90% of the initial public offering (“IPO”) price of $20.00 per share, through a private placement financing (the “Private Placement”), which took place concurrently with the IPO of the Company’s Common Stock.”

AECOM entered into Revolving Credit Agreement with Bank of America, N.A. valued at $500 million (effective 2026-06-10).

“On June 10, 2026, AECOM entered into that certain Credit Agreement (the “ Revolving Credit Agreement ”), by and among AECOM, as borrower, certain domestic subsidiaries of AECOM from time to time party thereto, as designated borrowers (together with AECOM, the “ Borrowers ”), the lenders from time to time party thereto (the “ Lenders ”) and Bank of America, N.A. (the “ Administrative Agent ”) as administrative agent and swing line lender. The Revolving Credit Agreement provides for a $500 million revolving credit facility”

VSEE HEALTH, INC. entered into Securities Purchase Agreement with an institutional investor valued at aggregate principal amount of $271,739.13 (effective 2026-06-08).

“On June 8, 2026, VSee Health, Inc., a Delaware corporation (the “Company”) entered into a securities purchase agreement (the “SPA”) with an institutional investor (the “Holder”).”

VSEE HEALTH, INC. entered into Standby Equity Purchase Agreement with YA II PN, LTD. valued at up to $10 million (effective 2026-06-02).

“On June 2, 2026 (the “Effective Date”), VSee Health, Inc. (the “Company”) entered into a Standby Equity Purchase Agreement (the “SEPA”) with YA II PN, LTD., a Cayman Islands exempt limited company (the “Investor”).”

Melar Acquisition Corp. I/Cayman entered into Note with Melar Acquisition Sponsor I LLC valued at up to $1,500,000 (effective 2026-06-11).

“On June 11, 2026, Melar Acquisition Corp. I, a Cayman Islands exempted company (the “ Company ”), issued a promissory note (the “ Note ”) in the aggregate principal amount of up to $1,500,000 to Melar Acquisition Sponsor I LLC, the Company’s sponsor (the “ Sponsor ”).”

Cardiff Lexington Corp entered into Purchase Agreement with an institutional investor valued at up to $25,000,000 (effective 2026-06-05).

“On June 5, 2026, Cardiff Lexington Corporation, a Nevada corporation (the “ Company ”), entered into a common stock purchase agreement (the “ Purchase Agreement ”) and a registration rights agreement (the “ Registration Rights Agreement ”) with an institutional investor (the “ Investor ”), pursuant to which the Investor has committed to purchase up to $25,000,000 of shares of the Company’s common stock”

Venture Global, Inc. entered into Indenture for 6.375% Senior Secured Notes due 2034 and 6.625% Senior Secured Notes due 2036 with The Bank of New York Mellon, as trustee and collateral agent valued at $1.125 billion each, for $2.25 billion aggregate principal amount of senior secured notes (effective 2026-06-11).

“On June 11, 2026, Venture Global LNG, Inc. (“VGLNG”), a wholly-owned subsidiary of Venture Global, Inc. (“Venture Global”, “we”, “us” or “our”) completed its previously announced offering (the “Notes Offering”) of (i) $1.125 billion aggregate principal amount of 6.375% senior secured notes due 2034 (the “2034 Notes”) and (ii) $1.125 billion aggregate principal amount of 6.625% senior secured notes due 2036 (the “2036 Notes” and, collectively with the 2034 Notes, the “Notes”).”

Vireo Growth Inc. entered into Securities Purchase Agreement with Bridgewell Agribusiness LLC, BWAB Holdings, LLC, Agribusiness Holdings Limited Partnership, the persons listed as "Ultimate Sellers" on Schedule I to the Purchase Agreement valued at US$40 million (effective 2026-06-05).

“On June 5, 2026, Vireo Growth Inc. (the “Company”), entered into a Securities Purchase Agreement (the “Purchase Agreement”) with Bridgewell Agribusiness LLC, an Oregon limited liability company (“Bridgewell”), BWAB Holdings, LLC, an Oregon limited liability company (“BWAB Holdings”), Agribusiness Holdings Limited Partnership, an Oregon limited partnership (“Agribusiness Holdings”), the persons listed as “Ultimate Sellers” on Schedule I to the Purchase Agreement (each, a “Seller” and, collectively, the “Sellers”) and certain other parties thereto.”

GLADSTONE INVESTMENT CORPORATION\DE amended Amendment No. 13 with KeyBank National Association (effective 2026-06-10).

“On June 10, 2026, Gladstone Investment Corporation (the “Company”), through its wholly-owned subsidiary Gladstone Business Investment, LLC, entered into Amendment No. 13 (the “Amendment”) to its Fifth Amended and Restated Credit Agreement with KeyBank National Association (“KeyBank”), as administrative agent, joint lead arranger and lender, Fifth Third Bank as managing agent, joint lead arranger and lender, City National Bank as joint lead arranger and lender, Gladstone Management Corporation, the Company’s Adviser, as servicer, and certain other lenders party thereto (together with the Amendment, the “Credit Facility”).”

Blue Owl Credit Income Corp. entered into Purchase Agreement with Wells Fargo Securities, LLC, Credit Agricole Securities (USA) Inc., ING Financial Markets LLC, RBC Capital Markets, LLC and SMBC Nikko Securities America, Inc., as representatives of the several initial purchasers valued at $500 million aggregate principal amount (effective 2026-06-08).

“The offering was consummated pursuant to the terms of a purchase agreement (the “Purchase Agreement”), dated June 8, 2026, among the Company and Blue Owl Credit Advisors LLC, on the one hand, and Wells Fargo Securities, LLC, Credit Agricole Securities (USA) Inc., ING Financial Markets LLC, RBC Capital Markets, LLC and SMBC Nikko Securities America, Inc., as representatives of the several initial purchasers listed on Schedule 1 thereto (the “Initial Purchasers”), on the other hand.”

CarMax Select Receivables Trust 2026-B entered into Underwriting Agreement with Wells Fargo Securities, LLC, as representative of the several underwriters named therein valued at $569,997,000 aggregate principal balance (effective 2026-06-09).

“On June 9, 2026, CarMax Business Services, LLC (“CarMax Business Services”) and CarMax Auto Funding LLC (the “Depositor”) entered into an Underwriting Agreement with Wells Fargo Securities, LLC, as representative of the several underwriters named therein (collectively, the “Underwriters”), whereby each of the Underwriters has severally agreed to purchase $569,997,000 aggregate principal balance of various classes of Asset-backed Notes to be issued by CarMax Select Receivables Trust 2026-B”

GRIFFON CORP entered into Second Lien Tranche A Credit Agreement with Merv FinCo LLC (Borrower), UMB Bank, N.A. valued at Tranche A second lien term loans in the aggregate principal amount of $90.0 million (effective 2026-06-09).

“Second Lien Tranche A Credit Agreement (the “ Tranche A Credit Agreement ”), by and among the Borrower, MidCo, the guarantors from time to time party thereto, the Griffon Lender, as lender, and UMB Bank, N.A., as administrative agent, and (ii) a Second”

GRIFFON CORP entered into Amended and Restated Master Transaction Agreement with VNPI Global Investments and Services, S.L., Bellota Holding AG, Merv HoldCo LLC, Merv MidCo LLC, Merv FinCo LLC (effective 2026-06-07).

“The closing was pursuant to an amended and restated master transaction agreement (“ A&R MTA ”), as described below. On February 5, 2026,”

Hyundai Auto Receivables Trust 2026-B entered into Underwriting Agreement with Citigroup Global Markets Inc., on its own behalf and as representative of the several underwriters valued at $2,187,070,000 (effective 2026-06-09).

“On June 9, 2026, Hyundai ABS Funding, LLC (“HABS”), Hyundai Capital America (“HCA”) and Citigroup Global Markets Inc., on its own behalf and as representative of the several underwriters (the “Underwriters”) entered into an Underwriting Agreement, pursuant to which notes in the following classes: Class A-1, Class A-2-A, Class A-2-B, Class A-3, Class A-4, Class B and Class C Asset Backed Notes (collectively, the “Notes”) with an aggregate principal balance of $2,187,070,000 were sold to the Underwriters.”

BADGER METER INC amended Amended Facility with each lender and agent listed on the signature pages thereof valued at $150 million (effective 2026-06-05).

“On June 5, 2026, Badger Meter, Inc. (the “Company”) amended and extended its $150 million multi-currency revolving credit facility, with an extended maturity date of July 8, 2031 (the “Amended Facility”).”

ADIAL PHARMACEUTICALS, INC. entered into Merger Agreement with Azora.

“Pursuant to the terms of the Merger Agreement, each option to purchase Azora common stock that was outstanding immediately prior to the First Effective Time was assumed by the Company”

Porch Group, Inc. entered into Securities Purchase Agreement with Porch Reciprocal Exchange valued at 2,092,050 shares for $14,999,998.50 (effective 2026-06-10).

“On June 10, 2026 (the “Effective Date”), Porticus Reinsurance Ltd. (“Porticus”), a Cayman Islands captive reinsurance company and subsidiary of Porch Group, Inc. (the “Company” or “Porch”), entered into a Securities Purchase Agreement (the “SPA”) with the Porch Reciprocal Exchange, a Texas unincorporated reciprocal inter-insurance exchange (the “Reciprocal”).”

Edesa Biotech, Inc. entered into Registration Rights Agreement with the Purchasers valued at Company agrees to file registration statement for resale of shares within 45 days after Closing (effective 2026-06-10).

“Also on June 10, 2026, the Company entered into a Registration Rights Agreement (the “Registration Rights Agreement”) with the Purchasers.”